<DOC>
	<DOCNO>NCT01550770</DOCNO>
	<brief_summary>Exploration hypothesis general anesthesia singular threshold continuum central nervous system depression dependent interpretation nociceptive stimulus .</brief_summary>
	<brief_title>Exploratory Study Propofol Fentanyl Pharmacodynamics</brief_title>
	<detailed_description />
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<criteria>American Society Anesthesia ( ASA ) classification score III male female volunteer Normal healthy individual medical history physical examination Uncomplicated airway anatomy Body Mass Index ( BMI ) 1829 Subject willing give consent comply evaluation treatment schedule 1855 year age ( inclusive ) Negative durg screen marijuana , cocaine , ecstasy , phencyclidine ( PCP ) , amphetamine , benzodiazepine , opiates methamphetamine Woman childbearing age byst utilize reliable mean contraception Able read , speak understand English Physical psychological condition would impair study participation determine principal investigator Known suspect neurological pathology assess principal investigator History significant alcohol drug abuse , history allergy opioids propofol , history chronic drug requirement medical illness know alter pharmacokinetics pharmacodynamics fentanyl and/or propofol Known suspect hypersensitivity study drug Taken medication within 2 day prior study drug administration , exception oral contraceptive Baseline tolerance 50 mA TES Pregnancy lactation Consumed food within 8 hour liquid within 4 hour prior study drug administration Participation investigational device durg study within 30 day enrollment Diagnosis sleep apnea Current prescription antidepressant antianxiety medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>